Market Overview

Tickers

Articles

Keywords

Search by keyword...
googlecse
5968
Articles
1.00M
Views

About

Jonathan Chen is a senior writer for Benzinga who covers a wide array of topics. He covers politics, technology, and commodity related issues, as well as macro issues. He enjoys reading about the latest dealings in the technology space, as well as keeping up on current political events. In his free time, Jonathan enjoys following his favorite sports teams, the Mets, and Patriots, as well as working working out and leading a healthy lifestyle.

Author Profile

Jonathan Chen

 

Is Your Startup About to Power Down?
11/18/2011 - 2:59pm
Venture capital firms are the life blood of the Internet industry, as new firms pop up seemingly every day in a variety of different fields. Heck, Benzinga is funded by a venture capital firm, LightBank, which was funded by Eric Lefkofsky and Brad Keywell, co-founders of
Mortal Kombat: Apple, Amazon Finish Tablet Competition
11/18/2011 - 1:42pm
If your name isn't Apple (NASDAQ: AAPL) or Amazon (NASDAQ: AMZN), don't bother trying to make a tablet. AppleInsider is reporting via the
Indigo Equity Research Neutral on Dell
11/18/2011 - 12:17pm
Indigo Equity Research is out with a research report on Dell (NASDAQ: DELL) and it has a Neutral rating on shares. In a note to clients, Indigo Equity Research writes, "Dell's recent turnaround strategy has been focused on improving margins, which has sacrificed revenues. - Dell has grown its higher margin IT services, software and data centres (
Bank of America Merrill Lynch Neutral on Medicis Pharmaceutical
11/18/2011 - 12:14pm
Bank of America Merrill Lynch is out with a research report on Medicis Pharmaceutical Corporation (NYSE: MRX) and it has a Neutral rating and a $40 price target on shares. In a note to clients, Bank of America Merrill Lynch writes, "MRX shares are down >10% since the 3Q call (11/8), which we believe is due in part to concerns about Solodyn sales (50%
Bank of America Merrill Lynch Underperform on Blue Coat Systems
11/18/2011 - 12:10pm
Bank of America Merrill Lynch is out with a research report on Blue Coat Systems, Inc (NASDAQ: BCSI) and it has an Underperform rating and a $17 price target on shares. In a note to clients, Bank of America Merrill Lynch writes, "2Q sales/EPS of $114mn/$0.20 beat our and Street's estimates of ~$107mn/$0.13.
Fed Buys $2.5 Billion During POMO as Part of Operation Twist
11/18/2011 - 12:03pm
The New York Federal Reserve purchased $2.541 billion in U.S.
Metals Rebounding, Silver Leading
11/18/2011 - 11:30am
Silver is leading the metals sector this morning, in this Friday edition of the Metals Morning Update. Equities are mixed, with the Dow and S&P 500 higher, and the NASDAQ is lower at this time. Gold is up $1.70 an ounce, to trade at $1,721.90, a gain of 0.1%.
Super Mario Increased His Fire Power, But It Isn't Enough
11/18/2011 - 10:57am
Super Mario is able to do it again, at least for a little while. ECB President Mario Draghi and the rest of the European Central Bank have now been given the approval to purchase $27 billion worth of sovereign debt every week, as Europe tries to stave off a debt crisis of epic proportions.
Benzinga's Daily Laugh November 19, 2011
11/18/2011 - 10:13am
Here's today's daily laugh. Must be why my cell phone bill is sky high.
Credit Suisse Upgrading Smithfield Foods
11/18/2011 - 10:06am
Credit Suisse is out with a research report on Smithfield Foods (NYSE: SFD) and it is upgrading shares to Outperform and is raising its price target to $29 from $23. In a note to clients, Credit Suisse writes, "We are raising our Smithfield rating to Outperform from Neutral, and our target price to $29 from $23.

Get Benzinga's News Delivered Free

Benzinga Professional

Subscribe